Evidence map›Paper›PMID 36714874›Full record

ArticlePNAS nexus2022

Plasmonic gadolinium oxide nanomatryoshkas: bifunctional magnetic resonance imaging enhancers for photothermal cancer therapy.

Luke Henderson, Oara Neumann, Yara Kadria-Vili, Burak Gerislioglu, James Bankson, Peter Nordlander, Naomi J Halas

Open access · goldAbstract read
In one paragraph

Article in PNAS nexus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Luke HendersonDepartment of Chemistry, Rice University, 6100 Main St, Houston, TX 77005, USA.
Oara NeumannLaboratory for Nanophotonics, Rice University, 6100 Main St, Houston, TX 77005, USA.
Yara Kadria-ViliDepartment of Chemistry, Rice University, 6100 Main St, Houston, TX 77005, USA.
Burak GerisliogluLaboratory for Nanophotonics, Rice University, 6100 Main St, Houston, TX 77005, USA.
James BanksonDepartment of Imaging Physics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, TX 77030, USA.ORCID https://orcid.org/0000-0002-8574-154X
Peter NordlanderLaboratory for Nanophotonics, Rice University, 6100 Main St, Houston, TX 77005, USA.ORCID https://orcid.org/0000-0002-1633-2937
Naomi J HalasDepartment of Chemistry, Rice University, 6100 Main St, Houston, TX 77005, USA.ORCID https://orcid.org/0000-0002-8461-8494
Rice University · USThe University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

Nanoparticle-assisted laser-induced photothermal therapy (PTT) is a promising method for cancer treatment; yet, visualization of nanoparticle uptake and photothermal response remain a critical challenge. Here, we report a magnetic resonance imaging-active nanomatryoshka (Gd

Indexed as

gadoliniumgadolinium oxideMRI contrast agentsnanomatryoshkaphotothermal cancer therapy

Identifiers

PMID36714874
PMCPMC9802487
OpenAlexW4288690401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.